Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-10-31
2006-10-31
Campbell, Bruce R. (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023700, C536S023720, C435S069100, C435S235100, C435S239000, C435S320100
Reexamination Certificate
active
07129342
ABSTRACT:
The present invention relates to nucleic acid sequence which comprises the genome of an infectious GB virus B clone. The invention also relates to the use of the nucleic acid sequence of the infectious GB virus B clone to indirectly study the molecular properties of HCV, and in the production of HCV/GBV-B chimeras. The invention further relates to the use of the infectious nucleic acid sequence of GB virus B clone and the HCV/GBV-B chimeras in the development of vaccines and therapeutics for HCV.
REFERENCES:
patent: 6627437 (2003-09-01), Traboni
patent: 2003/0054505 (2003-03-01), Jin et al.
patent: 2004/0039187 (2004-02-01), Martin et al.
patent: WO 95/21922 (1995-08-01), None
patent: WO 00/73466 (2000-12-01), None
Scarselli et al., Journal of Virology, vol. 71 No. 7, pp. 4985-4989 (Jul. 1997).
Bowie et al., Science, vol. 247 No. 4948, pp. 1306-1310 (Mar. 1990).
Simons et al., Proceedings of the National Academy of Sciences, USA, vol. 92 No. 8, pp. 3401-3405 (Apr. 1995).
Yoo et al., Veterinary Immunology and Immunopathology, vol. 102 No. 3, pp. 143-154 (Dec. 2004).
Buhk, Jens et al, “Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent.” Virology 262:2 (pp. 470-478) Sep. 1999.
Butkiewicz, N. et al, “Virus specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.” J. Virol 74:9 ( pp. 4291-4301) May 2000.
Honda, Masao et al, “A phylogenetically conserved stem loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation.” Journal of Virology 73:2 (pp. 1165-1174) Feb. 1999.
Sbardellati, Andrea et al “Indentification of a novel sequence at the 3′ end of the GB virus B genome.” Journal of Virology 73:12 (pp. 10546-10550) Dec. 1999.
Scarselli, Elisa et al. “GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity.” Journal of Virology 71:7 (pp. 4985-4989) Jul. 1997.
Yanagi, M et al, “Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo” Virology 244:1 (pp. 161-172).
Yanagi, Masayuki et al, “In vivo analysis of the 3′ untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone.” Proceedings of the National Academy of Sciences of the United States 96:5 (pp. 2291-2295) Mar. 1999.
Kolykhalov, A.A. et al. (1996) “Indentification of a Highly Conserved Sequence Element at the 3′ Terminus of Hepatitis C Virus Genome RNA” J Virol 70(6): 3363-3371.
Official Communication from the European Patent Office corresponding to application EP 00 939 534.4, 2004.
Bukh Jens
Emerson Suzanne U.
Purcell Robert H.
Yanagi Masayuki
Campbell Bruce R.
Knobbe Martens Olson & Bear LLP
Lucas Zachariah
The United States of America as represented by the Department of
LandOfFree
Infectious cDNA clone of GB virus B and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Infectious cDNA clone of GB virus B and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Infectious cDNA clone of GB virus B and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3622337